Keywords: Clinical Data, Viibryd, Vilazodone, USA, FDA, Depressive disorder

US FDA approves Clinical Data’s Viibryd to treat major depressive disorder

Article | 24 January 2011

Print This

The US Food and Drug Administration on Friday approved Clinical Data’s (Nasdaq: CLDA) Viibryd (vilazodone hydrochloride) to treat ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in